Modulation of Ghrelin O-Acyltransferase Expression in Pancreatic Islets

被引:39
|
作者
An, Wenjiao [1 ]
Li, Yin [1 ]
Xu, Geyang [1 ]
Zhao, Jing [1 ]
Xiang, Xinxin [1 ]
Ding, Li [1 ]
Li, Jing [1 ]
Guan, Youfei [1 ]
Wang, Xian [1 ]
Tang, Chaosu [1 ]
Li, Xiaoying [3 ]
Mulholland, Michael [2 ]
Zhang, Weizhen [1 ,2 ]
机构
[1] Peking Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, Beijing 100191, Peoples R China
[2] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA
[3] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Endocrinol & Metab Res, Ruijin Hosp, Shanghai 200030, Peoples R China
基金
中国国家自然科学基金;
关键词
Ghrelin O-acyltransferase; Insulin; Pancreatic islet cells; Mammalian target of rapamycin; STIMULATES INSULIN-SECRETION; MAMMALIAN TARGET; BETA-CELLS; NEUROPEPTIDE-Y; INS-1; CELLS; RAT; PATHWAY; GLUCOSE; GROWTH; LINE;
D O I
10.1159/000322338
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background: Ghrelin, the only identified circulating orexigenic signal, is unique in structure in which a specific acyl-modification of its third serine occurs. This acylation is necessary for ghrelin to bind to its receptor and to exert its biologic activity, which is catalyzed by ghrelin O-acyltransferase (GOAT). Although ghrelin is mainly secreted from gastric X/A like endocrine cells, it is also expressed in pancreatic islet cells and regulates insulin secretion. In this study, we examined the expression and regulation of GOAT in pancreas. Methods: GOAT mRNA and immunoreactivity were examined in pancreatic islets and INS-1 cells by RT-PCR and immunofluorescent staining or Western blotting. Results: Insulin inhibits the expression of GOAT mRNA and GOAT promoter activity in a dose and time-dependent manner. The mammalian target of rapamycin (mTOR) is activated by insulin. Blocking mTOR signaling by either rapamycin or overexpression of its negative regulator tuberous sclerosis complex 1 (TSC1) or TSC2 attenuates the inhibitory effect of insulin on the transcription and translation of GOAT. Conclusion: Our study suggests that GOAT is present in pancreatic islet cells and that insulin inhibits the expression of GOAT via the mediation of mTOR signaling. Copyright (C) 2010 S. Karger AG, Basel
引用
收藏
页码:707 / 716
页数:10
相关论文
共 50 条
  • [41] Ghrelin O-acyltransferase (GOAT), a specific enzyme that modifies ghrelin with a medium-chain fatty acid
    Kojima, Masayasu
    Hamamoto, Akie
    Sato, Takahiro
    JOURNAL OF BIOCHEMISTRY, 2016, 160 (04): : 189 - 194
  • [42] Investigation of functionally essential cysteine residues within human ghrelin O-acyltransferase
    Aiduk, Michael
    Davis, Tasha
    Hougland, James
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [43] Discovery of novel inhibitors of ghrelin O-acyltransferase enzyme: an in-silico approach
    Hosseini, Faezeh Sadat
    Ghassempour, Alireza
    Amanlou, Massoud
    RESEARCH IN PHARMACEUTICAL SCIENCES, 2022, 17 (05) : 540 - 557
  • [44] Targeting weight gain and glucose control with a designed Ghrelin O-acyltransferase inhibitor
    Hwang, Yousang
    Barnett, Brad
    Taylor, Martin
    Bowers, Erin
    Mukherjee, Chandrama
    Song, W-Jimmy
    Hussain, Mehboob A.
    Boeke, Jef D.
    Cole, Philip
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238 : 803 - 803
  • [45] cat-ELCCA: A Robust Method To Monitor the Fatty Acid Acyltransferase Activity of Ghrelin O-Acyltransferase (GOAT)
    Garner, Amanda L.
    Janda, Kim D.
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2010, 49 (50) : 9630 - 9634
  • [46] Anorexia of ageing is associated with elevated fasted and lower post-prandial ghrelin, independent of ghrelin O-acyltransferase
    Holliday, Adrian
    Warner, Jordan
    Hulston, Carl J.
    Corfe, Bernard M.
    Crabtree, Daniel R.
    APPETITE, 2024, 196
  • [47] The ghrelin O-acyltransferase–ghrelin system reduces TNF-α-induced apoptosis and autophagy in human visceral adipocytes
    A. Rodríguez
    J. Gómez-Ambrosi
    V. Catalán
    F. Rotellar
    V. Valentí
    C. Silva
    C. Mugueta
    M. R. Pulido
    R. Vázquez
    J. Salvador
    M. M. Malagón
    I. Colina
    G. Frühbeck
    Diabetologia, 2012, 55 : 3038 - 3050
  • [48] A Modular Customizable Ligand-Conjugate (LC) System Targeting Ghrelin O-Acyltransferase
    Ford, Amber L.
    Taft, Caine W.
    Sprague-Getsy, Andrea M.
    Carlson, Gracie C.
    Mate, Nilamber A.
    Sieburg, Michelle A.
    Chisholm, John D.
    Hougland, James L.
    BIOMOLECULES, 2025, 15 (02)
  • [49] Dietary caprylic acid and ghrelin O-acyltransferase activity to modulate octanoylated ghrelin functions: What is new in this nutritional field?
    Lemarie, Fanny
    Beauchamp, Erwan
    Drouin, Gaetan
    Legrand, Philippe
    Rioux, Vincent
    PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2018, 135 : 121 - 127
  • [50] The Efficacy, Safety, and Pharmacology of a Ghrelin O-Acyltransferase Inhibitor for the Treatment of Prader-Willi Syndrome
    Miller, Jennifer L.
    Lacroix, Andre
    Bird, Lynne M.
    Shoemaker, Ashley H.
    Haqq, Andrea
    Deal, Cheri L.
    Clark, Kristie A.
    Ames, Michael H.
    Suico, Jeffrey G.
    de la Pena, Amparo
    Fortier, Caroline
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (06): : E2373 - E2380